Vetnox LLC.

PAPiSOL treatment platforms adoption rates 1%, 3%, 6% and 10% oral and 5%, 10%, 15% 20% injectable revenue years 1-4, est. $4.9M, $14.1M, $28.4M $46.9M.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Tucson, Arizona, US
  • Currency USD
  • Founded 2005
  • Employees 3
  • Website anoxacorp.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free